346 related articles for article (PubMed ID: 10326535)
1. Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.
Lancet; 1998 May; 351(9115):1535-9. PubMed ID: 10326535
[TBL] [Abstract][Full Text] [Related]
2. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.
Mazzaferro V; Romito R; Schiavo M; Mariani L; Camerini T; Bhoori S; Capussotti L; Calise F; Pellicci R; Belli G; Tagger A; Colombo M; Bonino F; Majno P; Llovet JM;
Hepatology; 2006 Dec; 44(6):1543-54. PubMed ID: 17133492
[TBL] [Abstract][Full Text] [Related]
4. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
5. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
[TBL] [Abstract][Full Text] [Related]
7. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
[TBL] [Abstract][Full Text] [Related]
8. The long-term course of chronic hepatitis B.
Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
10. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
11. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
12. [The natural course of hepatitis B and hepatitis C virus infection].
Schwabe RF; Stremmel W
Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
14. Impact of interferon-alpha therapy on the development of hepatocellular carcinoma in patients with liver cirrhosis: results of an international survey.
Bonino F; Oliveri F; Colombatto P; Brunetto MR
J Viral Hepat; 1997; 4 Suppl 2():79-82. PubMed ID: 9429213
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
16. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
[TBL] [Abstract][Full Text] [Related]
17. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
18. Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels.
Miyaguchi S; Watanabe T; Takahashi H; Nakamura M; Saito H; Ishii H
Hepatogastroenterology; 2002; 49(45):724-9. PubMed ID: 12063979
[TBL] [Abstract][Full Text] [Related]
19. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
20. Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G; Giustina G; Sanchez-Tapias J; Quero C; Mas A; Olivotto PG; Solinas A; Almasio P; Hadziyannis S; Degos F; de Moura MC; Krogsgaard K; Pantalena M; Realdi G; Corrocher R; Schalm SW
Am J Gastroenterol; 1998 Jun; 93(6):896-900. PubMed ID: 9647014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
